From drug discovery through commercialization, Camargo Pharmaceutical Services specializes in designing and delivering streamlined, on-target drug development strategy. The company’s strategic drug development program design and implementation, from end-to-end or at any intermediate stage, includes pre-clinical feasibility assessments, CMC and CMO services, clinical program development, pharmacokinetics, CRO services, Phase I through IV studies and clinical trials, to regulatory review and submission via eCTD of INDs, NDAs, ANDAs, and 505(b)(2)s. Camargo Pharmaceutical Services designs and delivers strategic drug development programs for virtual, small and mid-sized pharmaceutical companies in the US and abroad.